Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm

Drug resistance is driven by genetic-epigenetic memory that enables cancer cells to adopt multiple phenotypic states depending on environmental conditions, supporting integration of evolutionary principles into biomarker discovery and personalized treatment strategies. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-06-11
DOI
https://doi.org/10.1158/0008-5472.can-25-0999
Citations
6
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
4.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm

Inmaculada Spiteri, Andrea Bertotti, Luca Magnani, Giulio Caravagna et al.
6 citations
Cancer Research
Epigenetics and DNA Methylation
4.84
article

Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm

Inmaculada Spiteri, Andrea Bertotti, Luca Magnani, Giulio Caravagna, Trevor A. Graham, Andrea Sottoriva, Erika Yara-Romero, Gianluca Ascolani, Georgios Vlachogiannis, Lucrezia Patruno, Érica A. Oliveira, Alex Graudenzi, Timon Heide, George D. Cresswell, Salvatore Milite, Ahmet Acar, Chela James, Nicola Valeri, Javier Fernández-Mateos, Bingjie Chen
article en
6 citations

Abstract

Drug resistance is driven by genetic-epigenetic memory that enables cancer cells to adopt multiple phenotypic states depending on environmental conditions, supporting integration of evolutionary principles into biomarker discovery and personalized treatment strategies. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.

Cancer ResearchVol. 85(15)
University of Trieste (IT), Institute of Cancer Research (GB), Middle East Technical University (TR), Breast Cancer Now (GB), 5T Torino (Italy) (IT), Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality (CN), Cambridge University Health Partners (GB), Human Technopole (IT), St Anna Children's Hospital (AT), Candiolo Cancer Institute (IT), St. Anna Children's Cancer Research Institute, Imperial College London (GB), University of Turin (IT), University of Milano-Bicocca (IT), Guangzhou Medical University (CN)
Eli Lilly and Company, Pfizer, AstraZeneca, Wellcome Trust, NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, Cancer Research UK, National Institute for Health and Care Research, Associazione Italiana per la Ricerca sul Cancro, Servier
Openalex Percentile: Top 5%
Epigenetics and DNA Methylation
4.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.